194805-15-7

Basic information

• Product Name: 5-BroMo-2,3-diMethyl-phenylaMine
• Synonyms: 5-BroMo-2,3-diMethyl-phenylaMine;Benzenamine, 5-bromo-2,3-dimethyl-
• CAS NO: 194805-15-7
• Molecular Formula: C₈H₁₀BrN
• Molecular Weight: 200.0757
• EINECS: -0
• Mol File: 194805-15-7.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-BroMo-2,3-diMethyl-phenylaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BroMo-2,3-diMethyl-phenylaMine(194805-15-7)
• EPA Substance Registry System: 5-BroMo-2,3-diMethyl-phenylaMine(194805-15-7)

Safety Data

• Hazardous Substances Data: 194805-15-7(Hazardous Substances Data)

Usage

General Description

5-Bromo-2,3-dimethyl-phenylamine is a chemical compound with the formula C8H10BrN. It is an aromatic amine with a bromine atom and two methyl groups attached to the phenyl ring. 5-BroMo-2,3-diMethyl-phenylaMine is used as a building block in organic synthesis and pharmaceutical research. It can also be used as a reagent in the preparation of various pharmaceutical intermediates and agrochemicals. Its chemical properties make it useful in the manufacturing of various chemical products, and it is important in the development of new drugs and materials.

Upstream product

• 18873-95-5 5-bromo-1,2-dimethyl-3-nitrobenzene 
• 83-41-0 2,3-dimethylnitrobenzene 
• 7439-89-6 iron 

Downstream Products

• 1423616-92-5 6-bromo-2-(4-decylphenyl)-4-methoxyisoindoline-1,3-dione 
• 1423616-94-7 2-(4-decylphenyl)-4-methoxy-6-((trimethylsilyl)ethynyl)isoindoline-1,3-dione 
• 203808-81-5 5-bromo-2,3-dimethylphenol 
• 194805-16-8 5-bromo-1-fluoro-2,3-dimethylbenzene 

Relevant articles and documents

COMPOSITIONS FOR USE IN METHODS OF INHIBITING PROTEIN KINASES

Identified compounds demonstrate protein kinase inhibitory activity and inhibition of dependent cell signaling pathways, such as NOD2 cell signaling. More specifically, the compounds are demonstrated to inhibit receptor interacting kinase 2 (RIPK2) and/or Activin- like kinase 2 (ALK2). Compounds that are either dual RIPK2/ALK2 inhibitors or that preferentially inhibit RIPK2 or ALK2 could provide therapeutic benefit.

4-Oxoquinolizine antimicrobial having 2-pyridone skeleton as partial structure

A compound represented by the following Formula (I) or a pharmaceutically acceptable salt thereof: 1wherein R1 represents a hydrogen atom or a carboxyl-protecting group, R2 represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group or a hydroxyl group, R3 represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a nitro group, a cyano group, a hydroxyl group or an amino group; R4 represents a hydrogen atom, an amino-protecting group, an alkyl group or a cycloalkyl group, and R5 represents a hydrogen atom, a halogen atom, an alkyl group, an alkenyl group, a cycloalkyl group, an aryl group, an alkoxy group, an alkylthio group, a hydroxyl group, an imino group or an amino group.